Thursday, September 21, 2017

#Cannabis Science Pioneer Tikun Olam Expands Partnership with MariMed (OTCQB: $MRMD), to Bring Branded Cannabis Products to More U.S. MMJ States

#Cannabis Science Pioneer Tikun Olam Expands Partnership with MariMed (OTCQB: $MRMD), to Bring Branded Cannabis Products to More U.S. MMJ States

Deal Combines Tikun Products & Unparalleled Research with MariMed's Cultivation & Distribution Networks

NEWTON, MA and NEW YORK, NY - September 21, 2017 (Investorideas.com Newswire) Tikun Olam, the world pioneer in cannabis research, and MariMed Inc. (OTCQB:MRMD), a preeminent management company in the U.S. medical cannabis industry, announced an expansion of their licensing agreement for Tikun Olam products to be grown, manufactured and sold through MariMed's network of managed and affiliated licensed facilities throughout the United States.

This new agreement brings Tikun Olam's premium cannabis products, years of proprietary, peer-reviewed scientific research and unprecedented clinical data collection to four additional MMJ-legal U.S. states, its most expansive agreement to date. Tikun Olam and MariMed's relationship began in 2015 with a pilot program in Delaware and marked the first time that U.S. patients had access to the world's only cannabis strains proven to deliver symptomatic relief for specific conditions including cancer, PTSD, epilepsy, Crohn's Disease/Colitis, chronic pain and neuropathy to name a few.





Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video


 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.